ATE135165T1 - Verwendung von alpha-d-galactosidase zur herstellung einer pharmazeutischen zusammensetzung zur linderung von gastro- intestinalen beschwerden durch alpha-d-galactosid gebundene zucker. - Google Patents
Verwendung von alpha-d-galactosidase zur herstellung einer pharmazeutischen zusammensetzung zur linderung von gastro- intestinalen beschwerden durch alpha-d-galactosid gebundene zucker.Info
- Publication number
- ATE135165T1 ATE135165T1 AT90907625T AT90907625T ATE135165T1 AT E135165 T1 ATE135165 T1 AT E135165T1 AT 90907625 T AT90907625 T AT 90907625T AT 90907625 T AT90907625 T AT 90907625T AT E135165 T1 ATE135165 T1 AT E135165T1
- Authority
- AT
- Austria
- Prior art keywords
- alpha
- galactoside
- galactosidase
- gastro
- relief
- Prior art date
Links
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical group OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 title abstract 5
- 102000005840 alpha-Galactosidase Human genes 0.000 title abstract 3
- 108010030291 alpha-Galactosidase Proteins 0.000 title abstract 3
- 230000002496 gastric effect Effects 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- WQZGKKKJIJFFOK-SVZMEOIVSA-N (+)-Galactose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-SVZMEOIVSA-N 0.000 abstract 4
- 230000037406 food intake Effects 0.000 abstract 3
- 241000124008 Mammalia Species 0.000 abstract 2
- 235000013305 food Nutrition 0.000 abstract 2
- 231100000252 nontoxic Toxicity 0.000 abstract 2
- 230000003000 nontoxic effect Effects 0.000 abstract 2
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 2
- 238000006243 chemical reaction Methods 0.000 abstract 1
- 230000009429 distress Effects 0.000 abstract 1
- 238000001727 in vivo Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01022—Alpha-galactosidase (3.2.1.22)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/06—Enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Nutrition Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Microbiology (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Dairy Products (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US35244189A | 1989-05-16 | 1989-05-16 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE135165T1 true ATE135165T1 (de) | 1996-03-15 |
Family
ID=23385155
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT90907625T ATE135165T1 (de) | 1989-05-16 | 1990-05-10 | Verwendung von alpha-d-galactosidase zur herstellung einer pharmazeutischen zusammensetzung zur linderung von gastro- intestinalen beschwerden durch alpha-d-galactosid gebundene zucker. |
Country Status (17)
| Country | Link |
|---|---|
| US (3) | US5989544A (de) |
| EP (1) | EP0472588B2 (de) |
| JP (1) | JPH0725695B2 (de) |
| KR (1) | KR0178029B1 (de) |
| AT (1) | ATE135165T1 (de) |
| AU (1) | AU629941B2 (de) |
| CA (2) | CA2055506C (de) |
| DE (1) | DE69025933T3 (de) |
| DK (1) | DK0472588T4 (de) |
| ES (1) | ES2084696T5 (de) |
| FI (1) | FI915402A0 (de) |
| GR (1) | GR1000903B (de) |
| IE (1) | IE81156B1 (de) |
| NZ (1) | NZ233582A (de) |
| PE (1) | PE2591A1 (de) |
| WO (1) | WO1990014101A1 (de) |
| ZA (1) | ZA903749B (de) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5436003A (en) * | 1994-02-10 | 1995-07-25 | Triarco Industries, Inc. | Method of alleviating gastrointestinal distress with a composition containing beta-fructofuransidase, cellulase and hemi-cellulase |
| US6099844A (en) * | 1994-08-22 | 2000-08-08 | Triarco Industries, Inc. | Increasing yield of extractable substances from botanicals with an enzyme composition |
| WO1997013526A1 (en) * | 1995-10-10 | 1997-04-17 | Novo Nordisk A/S | Method of improving lipid digestion |
| DE69815516T2 (de) * | 1998-06-24 | 2004-05-06 | Sraum Di Ezio Bartocci & C. S.A.S. | Lebensmittel basierend auf Cerealien, insbesondere für die menschliche Ernährung |
| IL125423A (en) * | 1998-07-20 | 2004-08-31 | Israel State | Alkaline alpha-galactosidase having broad substrate specificity |
| US20060198934A1 (en) * | 2005-03-01 | 2006-09-07 | Ronald S.O. Zane | Process for removing flatulence-associated oligosaccharides in legumes |
| EP2120892A4 (de) * | 2007-02-14 | 2011-05-18 | Neil A Solomon | Lactaseformulierung |
| MX2010012479A (es) * | 2010-11-16 | 2012-05-16 | Posi Visionary Solutions Llp | Composicion farmaceutica de administracion oral para el tratamiento del sindrome de intestino irritable, a base de un modificador de la motilidad intestinal, un agente que previene la retencion de gases y enzimas digestivas y proceso para su preparacion. |
| ITMI20111154A1 (it) * | 2011-06-24 | 2012-12-25 | Promefarm Srl | Composizioni farmaceutiche o nutrizionali comprendenti galattosidasi e loro uso |
| US20130084313A1 (en) * | 2011-09-30 | 2013-04-04 | Stomavite, Llc | Supplement for ostomy patients |
| US9402885B2 (en) | 2013-07-15 | 2016-08-02 | Alfa Wassermann S.P.A. | Method of treating GERD with alpha and beta galactosidases |
| WO2017202966A1 (en) * | 2016-05-24 | 2017-11-30 | Novozymes A/S | Polypeptides having alpha-galactosidase activity and polynucleotides encoding same |
| US20230303993A1 (en) * | 2020-07-23 | 2023-09-28 | Kiwi Health, Inc | Food supplement composition to aid in digestion of fructan, mannitol, and sorbitol |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1008583A (en) * | 1961-04-25 | 1965-10-27 | Olin Mathieson | Controlled release medicaments |
| US3493652A (en) * | 1962-09-14 | 1970-02-03 | Charles W Hartman | Controlled release medicament |
| US3479122A (en) | 1967-04-05 | 1969-11-18 | Takaji Funahashi | Writing instrument |
| US3632346A (en) * | 1968-04-30 | 1972-01-04 | Rohm & Haas | Process for rendering innocuous flatulence-producing saccharides |
| JPS4826978A (de) * | 1971-08-12 | 1973-04-09 | ||
| US3846239A (en) * | 1972-07-24 | 1974-11-05 | Monsanto Co | Process for the preparation of heat-resistant alpha-galactosidase enzyme |
| US3795585A (en) * | 1972-08-31 | 1974-03-05 | Agency Ind Science Techn | Method for manufacture of alpha-galactosidase |
| CH585793A5 (de) * | 1974-02-01 | 1977-03-15 | Nestle Sa | |
| GB1446965A (en) * | 1974-02-14 | 1976-08-18 | Agricultural Vegetable Prod | Preparation of food products |
| JPS5344556B2 (de) * | 1974-03-18 | 1978-11-29 | ||
| JPS5322158B2 (de) * | 1974-05-02 | 1978-07-06 | ||
| US4241185A (en) * | 1979-02-23 | 1980-12-23 | The Great Western Sugar Company | Method of stabilizing α-galactosidase |
| IT1130242B (it) * | 1980-02-01 | 1986-06-11 | Anic Spa | Procedimento per la produzione dell'enzima alfa-galattosidasi e per l'idrolisi del raffinosio mediante l'impiego dell'enzima stesso |
| US4376127A (en) * | 1981-01-23 | 1983-03-08 | Lunde Kenneth E | Process for deflatulating and improving the digestibility of legumes |
| JPS5843075B2 (ja) † | 1981-03-03 | 1983-09-24 | 株式会社 林原生物化学研究所 | α−Ｄ−ガラクトシダ−ゼの製造方法 |
| JPS5843075A (ja) * | 1981-09-09 | 1983-03-12 | Canon Inc | 印字装置付電子機器 |
| DE3273744D1 (en) | 1981-11-30 | 1986-11-20 | Navarro Josep Ramisa | Atomized-water dispersing apparatus |
| IT1140312B (it) * | 1981-12-03 | 1986-09-24 | Anic Spa | Procedimento per la produzione di alfa-galattosidasi e impieghi dell'enzima cosi' ottenuto |
| US4861718A (en) * | 1984-09-29 | 1989-08-29 | Wakamoto Pharmaceutical Co., Ltd. | Gene coding for thermostable beta-galactosidase, bacillus subtilis having the gene, enzyme coded by the gene and a process for the production thereof |
| DK80588A (da) | 1987-02-23 | 1988-08-24 | Suomen Sokeri Oy | Fjerkrae-foder, fodringsmetode og fremgangsmaade til forbedring af fordoejeligheden af fjerkrae-foder |
| FR2611778B1 (fr) * | 1987-02-26 | 1992-04-24 | Paris Ouest Entreprise | Plancher a collaboration bois-beton |
| FI78814C (fi) | 1987-03-30 | 1989-10-10 | Cultor Oy | Nollfiber innehaollande foderraoaemne och foder samt foerfarande foer deras framstaellning. |
| WO1990011353A1 (en) * | 1989-03-24 | 1990-10-04 | Research Corporation Technologies, Inc. | Recombinant alpha-galactosidase, a therapy for fabry disease |
| US5179023A (en) | 1989-03-24 | 1993-01-12 | Research Corporation Technologies, Inc. | Recombinant α-galactosidase a therapy for Fabry disease |
| FR2647638A1 (fr) | 1989-05-30 | 1990-12-07 | Euretec Gie | Composition alimentaire contenant un enzyme |
| US5436003A (en) | 1994-02-10 | 1995-07-25 | Triarco Industries, Inc. | Method of alleviating gastrointestinal distress with a composition containing beta-fructofuransidase, cellulase and hemi-cellulase |
-
1990
- 1990-05-07 NZ NZ233582A patent/NZ233582A/en unknown
- 1990-05-09 PE PE1990168877A patent/PE2591A1/es not_active IP Right Cessation
- 1990-05-10 AU AU56406/90A patent/AU629941B2/en not_active Expired
- 1990-05-10 EP EP90907625A patent/EP0472588B2/de not_active Expired - Lifetime
- 1990-05-10 WO PCT/US1990/002643 patent/WO1990014101A1/en not_active Ceased
- 1990-05-10 FI FI915402A patent/FI915402A0/fi unknown
- 1990-05-10 AT AT90907625T patent/ATE135165T1/de not_active IP Right Cessation
- 1990-05-10 CA CA002055506A patent/CA2055506C/en not_active Expired - Lifetime
- 1990-05-10 JP JP2507612A patent/JPH0725695B2/ja not_active Expired - Lifetime
- 1990-05-10 KR KR1019910700059A patent/KR0178029B1/ko not_active Expired - Fee Related
- 1990-05-10 DK DK90907625T patent/DK0472588T4/da active
- 1990-05-10 DE DE69025933T patent/DE69025933T3/de not_active Expired - Lifetime
- 1990-05-10 ES ES90907625T patent/ES2084696T5/es not_active Expired - Lifetime
- 1990-05-10 CA CA002329486A patent/CA2329486C/en not_active Expired - Lifetime
- 1990-05-15 IE IE174290A patent/IE81156B1/en not_active IP Right Cessation
- 1990-05-16 GR GR900100374A patent/GR1000903B/el not_active IP Right Cessation
- 1990-05-16 ZA ZA903749A patent/ZA903749B/xx unknown
-
1995
- 1995-06-07 US US08/487,871 patent/US5989544A/en not_active Expired - Lifetime
-
2000
- 2000-08-08 US US09/634,088 patent/US6344196B1/en not_active Expired - Fee Related
-
2002
- 2002-02-14 US US10/075,328 patent/US20020106366A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CA2055506A1 (en) | 1990-11-17 |
| ES2084696T3 (es) | 1996-05-16 |
| US6344196B1 (en) | 2002-02-05 |
| PE2591A1 (es) | 1991-02-05 |
| CA2055506C (en) | 2001-02-13 |
| EP0472588B2 (de) | 2002-01-02 |
| GR1000903B (el) | 1993-03-16 |
| EP0472588B1 (de) | 1996-03-13 |
| US20020106366A1 (en) | 2002-08-08 |
| ZA903749B (en) | 1991-08-28 |
| JPH0725695B2 (ja) | 1995-03-22 |
| DE69025933D1 (de) | 1996-04-18 |
| FI915402A7 (fi) | 1991-11-15 |
| JPH05500043A (ja) | 1993-01-14 |
| CA2329486C (en) | 2004-11-02 |
| KR0178029B1 (ko) | 1999-03-20 |
| GR900100374A (en) | 1991-10-10 |
| FI915402A0 (fi) | 1991-11-15 |
| EP0472588A1 (de) | 1992-03-04 |
| AU5640690A (en) | 1990-12-18 |
| WO1990014101A1 (en) | 1990-11-29 |
| DK0472588T3 (da) | 1996-04-01 |
| US5989544A (en) | 1999-11-23 |
| IE81156B1 (en) | 2000-05-03 |
| DE69025933T3 (de) | 2002-09-05 |
| NZ233582A (en) | 1992-05-26 |
| IE901742L (en) | 1990-11-16 |
| EP0472588A4 (en) | 1992-05-06 |
| CA2329486A1 (en) | 1990-11-17 |
| DK0472588T4 (da) | 2002-02-18 |
| DE69025933T2 (de) | 1996-09-05 |
| ES2084696T5 (es) | 2002-08-16 |
| KR920700680A (ko) | 1992-08-10 |
| AU629941B2 (en) | 1992-10-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE135165T1 (de) | Verwendung von alpha-d-galactosidase zur herstellung einer pharmazeutischen zusammensetzung zur linderung von gastro- intestinalen beschwerden durch alpha-d-galactosid gebundene zucker. | |
| Foster | Diabetes mellitus | |
| CA2271865A1 (en) | Tablet composition | |
| GR3003402T3 (en) | Vanadium-peroxide compositions as insulin mimickers | |
| DE3662789D1 (en) | Method for the preparation of esters of a non-reducing sugar or sugar alcohol and one or more fatty acids | |
| JPH0678235B2 (ja) | 胃腸粘膜組織障害疾患治療剤 | |
| ES2097162T3 (es) | Utilizacion de acidos grasos de cadena corta en alimentacion clinica. | |
| IS2234B (is) | Samsetning til að bæla fráhvarfseinkenni og fíkn í áfengi hjá áfengissjúklingum og fyrirbyggja misnotkun áfengis hjá heilbrigðum einstaklingum | |
| Okumura et al. | Inhibition of gastric pepsin secretion by peripherally or centrally injected interleukin-1 in rats | |
| SE8303401D0 (sv) | Beredning och dess anvendning | |
| Hewitt | Addison's disease occurring in sisters | |
| Euler et al. | Failure of a cytoprotective dose of arbaprostil to heal acute duodenal ulcers: results of a multiclinic trial | |
| DE3684882D1 (de) | Verwendung einer zusammensetzung zur herstellung eines medikaments zur verbesserung des zellstoffwechsels. | |
| Kemp | The adrenal cortex | |
| ES8603755A1 (es) | Un procedimiento para preparar un agente curativo y preventivo de ulceras a base de componentes de brotes de casia solubles en agua. | |
| MacDonald et al. | Protective action of carbenoxolone on pickle-induced gastric injury in man | |
| Meyer | Encephalitis after Measles with Parkinsonian Rigidity: Recovery | |
| DE69231583D1 (de) | Zusammensetzung zur Behandlung des Insulinmangels bei Säugetieren, die Amylin und Insulin enthält. | |
| Burns et al. | The Influence of Flesh-Feeding on Urinary Creatinine | |
| JP2005082504A (ja) | 免疫活性増強剤、並びにそれが含まれた食品および医薬部外品 | |
| TAKAHASHI | Transplacental effects of 3, 5-dimethyl-3′-isopropyl-L-thyronine on tubulin content in fetal brains in rats | |
| Perrie et al. | Electrophoretic study of the small subunits of the myosin molecule | |
| Anderson et al. | Case of Malignant Tertian Malaria | |
| Goldstone et al. | Trisomy-18 Syndrome: Case Report with Chromosomal Analysis | |
| KR20020004193A (ko) | 알콜 흡수 억제제를 함유한 숙취 제거 및 간장 보호용조성물 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| EEIH | Change in the person of patent owner | ||
| UEP | Publication of translation of european patent specification |
Ref document number: 0472588 Country of ref document: EP |
|
| EELA | Cancelled due to lapse of time |